Main Street Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$103K Hold
818
0.02% 173
2026
Q1
$114K Buy
+818
New +$115K 0.03% 155
2025
Q4
Sell
-618
Closed -$68.6K 288
2025
Q3
$68.6K Hold
618
0.02% 205
2025
Q2
$68.5K Sell
618
-312
-34% -$33.2K 0.02% 205
2025
Q1
$104K Buy
930
+312
+50% +$32.2K 0.04% 148
2024
Q4
$57.1K Sell
618
-232
-27% -$20.9K 0.02% 214
2024
Q3
$71.3K Sell
850
-800
-48% -$61K 0.03% 198
2024
Q2
$113K Sell
1,650
-721
-30% -$48.1K 0.05% 153
2024
Q1
$173K Buy
2,371
+771
+48% +$59.3K 0.08% 130
2023
Q4
$130K Buy
+1,600
New +$125K 0.05% 197

Other funds holding GILD

Main Street Group's GILD Position: Q2 2026 in Review

Main Street Group held its Gilead Sciences (GILD) position steady in Q2 2026 at 818 shares worth $103K. The position accounts for 0.02% of the portfolio, ranked #173.

Main Street Group first reported a position in GILD in Q4 2023 and has held it in 10 quarters since. The position peaked at $173K in Q1 2024. 361 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Main Street Group held 818 shares of Gilead Sciences worth $103K as of Q2 2026.
  • Main Street Group left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.02% of Main Street Group's portfolio in Q2 2026, its #173 holding.
  • Main Street Group first reported a position in Gilead Sciences in Q4 2023 and has held it in 10 quarters since.
  • Main Street Group's Gilead Sciences position peaked at $173K in Q1 2024.
  • 361 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Main Street Group's 13F filing for Q2 2026, filed 13 Jul 2026.